Anika Therapeutics Inc. (ANIK) Financial Statements (2024 and earlier)

Company Profile

Business Address 32 WIGGINS AVENUE
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments120,95494,38698,318184,943159,014157,256
Cash and cash equivalents86,32794,38695,817157,46389,042133,256
Short-term investments34,627 2,50127,48069,97224,000
Receivables34,62729,84324,10223,07920,77523,825
Inventory, net of allowances, customer advances and progress billings39,76536,01046,20921,99521,30022,035
Inventory39,76536,01046,20921,99521,30022,035
Other undisclosed current assets(25,799)8,2898,7544,2891,8543,211
Total current assets:169,547168,528177,383234,306202,943206,327
Noncurrent Assets
Operating lease, right-of-use asset30,69620,95722,61922,864
Property, plant and equipment48,27947,60250,61350,78354,11156,183
Intangible assets, net (including goodwill)81,93890,16399,57015,27917,04218,853
Goodwill7,3397,7818,4137,6947,8518,218
Intangible assets, net (excluding goodwill)74,59982,38291,1577,5859,19110,635
Deferred income tax assets1,449   
Other noncurrent assets17,21920,28515,4207,4784,8971,254
Total noncurrent assets:179,581179,007188,22296,40476,05076,290
TOTAL ASSETS:349,128347,535365,605330,710278,993282,617
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities24,84221,80520,76313,95510,19613,073
Taxes payable   385 
Employee-related liabilities9,5237,3455,8304,446 
Accounts payable9,0747,6338,9843,8323,1436,747
Accrued liabilities15,7684,6494,4344,2932,2226,326
Debt   148   
Business combination, contingent consideration, liability  4,31513,090   
Other undisclosed current liabilities3,0723,6752,8662,3221,093 
Total current liabilities:27,91429,79536,86716,27711,28913,073
Noncurrent Liabilities
Long-term debt and lease obligation:  19,24020,87921,367  
Liabilities, other than long-term debt35,65111,41535,4594,6884,0926,053
Deferred tax liabilities, net3,5425,393
Deferred income tax liabilities6,43610,15711,8954,331
Other liabilities3981,2581,244357550660
Operating lease, liability28,81719,24020,87921,367
Business combination, contingent consideration, liability   22,320   
Total noncurrent liabilities:35,65130,65556,33826,0554,0926,053
Total liabilities:63,56560,45093,20542,33215,38119,126
Equity
Equity, attributable to parent285,563287,085272,400288,378263,612263,491
Common stock146144143143142147
Additional paid in capital81,14167,08155,35548,70750,76368,617
Accumulated other comprehensive loss(6,443)(5,718)(4,542)(5,898)(5,526)(4,784)
Retained earnings210,719225,578221,444245,426218,233199,511
Total equity:285,563287,085272,400288,378263,612263,491
TOTAL LIABILITIES AND EQUITY:349,128347,535365,605330,710278,993282,617

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues156,236147,794130,457114,610105,555113,420
Revenue, net113,420
Cost of revenue
(Cost of Goods and Services Sold)
(62,660)(64,851)(61,431)(28,747)(31,280)(27,364)
Other undisclosed gross profit      
Gross profit:93,57682,94369,02685,86374,27586,056
Operating expenses(112,976)(101,423)(126,014)(51,615)(52,526)(40,327)
Other undisclosed operating income 21,09528,666   
Operating income (loss):(19,400)2,615(28,322)34,24821,74945,729
Interest and debt expense (11)(19)(25)   
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before equity method investments, income taxes:(19,411)2,596(28,347)34,24821,74945,729
Other undisclosed income (loss) from continuing operations before income taxes665(169)(277)1,8731,458473
Income (loss) from continuing operations before income taxes:(18,746)2,427(28,624)36,12123,20746,202
Income tax expense (benefit)3,8871,7074,642(8,928)(4,485)(14,386)
Income (loss) from continuing operations:(14,859)4,134(23,982)27,19318,72231,816
Income (loss) before gain (loss) on sale of properties:4,134(23,982)27,19318,72231,816
Net income (loss) available to common stockholders, diluted:(14,859)4,134(23,982)27,19318,72231,816

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(14,859)4,134(23,982)27,19318,72231,816
Other comprehensive income (loss)(725)(1,176)1,356(372)(742)2,533
Other undisclosed comprehensive loss      
Comprehensive income (loss):(15,584)2,958(22,626)26,82117,98034,349
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive income (loss), net of tax, attributable to parent:(15,584)2,958(22,626)26,82117,98034,349

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: